• Filing Date: 2016-03-30
  • Form Type: 10-K
  • Description: Annual report
v3.3.1.900
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Feb. 03, 2015
Mar. 16, 2016
Jan. 09, 2015
Aug. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Accounting Policies [Line Items]              
Research and Development in Process         $ 1,500,000    
Research and Development Expense, Total         13,757,279 $ 7,787,384  
Cash, Cash Equivalents, and Marketable Securities         $ 13,600,000 $ 8,000,000  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount         6,233,153 5,308,581  
Comprehensive Income (Loss), Net of Tax, Attributable to Parent         $ (12,847,954) $ (6,215,612)  
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax         9,385 980  
Stock Issued During Period, Shares, New Issues 1,658,822   2,839,045        
Shares Issued, Price Per Share $ 4.25   $ 3.523        
Stock Issued During Period, Value, New Issues $ 7,050,000   $ 10,000,000   16,446,218    
Amortization of Intangible Assets         48,749 10,733  
Depreciation         $ 62,116 $ 32,163  
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 2.27 $ 10.02 $ 17.20
Research and Development Arrangement [Member]              
Accounting Policies [Line Items]              
Government Grants Received       $ 2,900,000      
Grants Receivable         $ 2,400,000    
Subsequent Event [Member] | Investor [Member]              
Accounting Policies [Line Items]              
Stock Issued During Period, Shares, New Issues   1,692,151          
Shares Issued, Price Per Share   $ 2.40          
Stock Issued During Period, Value, New Issues   $ 4,100,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   846,073          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 4.50          
Subsequent Event [Member] | California Institute for Regenerative Medicine [Member]              
Accounting Policies [Line Items]              
CIRM Grant Award, Value   $ 3,400,000          
Maximum [Member]              
Accounting Policies [Line Items]              
Property, Plant and Equipment, Useful Life         7 years    
Minimum [Member]              
Accounting Policies [Line Items]              
Property, Plant and Equipment, Useful Life         5 years